This list is based on the watchlists of people on Stock Events who follow TD5A.MU. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Show more...
FAQ
What is Tandem Diabetes Care stock price today?▼
The current price of TD5A.MU is €16.5 EUR — it has increased by +5.77% in the past 24 hours. Watch Tandem Diabetes Care stock price performance more closely on the chart.
What is Tandem Diabetes Care stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tandem Diabetes Care stocks are traded under the ticker TD5A.MU.
Is Tandem Diabetes Care stock price growing?▼
TD5A.MU stock has fallen by -2.94% compared to the previous week, the month change is a +1.29% rise, over the last year Tandem Diabetes Care has showed a -12.86% decrease.
When is the next Tandem Diabetes Care earnings date?▼
Tandem Diabetes Care is going to release the next earnings report on May 07, 2026.
What were Tandem Diabetes Care earnings last quarter?▼
TD5A.MU earnings for the last quarter are -0.01 EUR per share, whereas the estimation was -0.08 EUR resulting in a +90.71% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Tandem Diabetes Care have?▼
As of May 06, 2026, the company has 2,650 employees.
In which sector is Tandem Diabetes Care located?▼
Tandem Diabetes Care operates in the Health & Wellness sector.
When did Tandem Diabetes Care complete a stock split?▼
Tandem Diabetes Care has not had any recent stock splits.
Where is Tandem Diabetes Care headquartered?▼
Tandem Diabetes Care is headquartered in San Diego, United States.